News
International News
Education
Environment
Healthcare
Technology
Internet
Science
Social and Non-Profit
Local News
Politicsand Policy
Government
Politics
Local Government
International Policy
Businessand Economy
Economy
Finance
Financial Markets
Jobs and Labor
Company News
Industry News
Aerospace
Agriculture
Chemicals
Commodities
Construction and Engineering
Consumer Electronics
Defense
Energy
Nuclear Energy
Oil and Gas
Renewable Energy
Financial Services
Banking
Insurance
Fishing and Aquaculture
Manufacturing
Information Technology
Metals and Mining
Pharmaceuticals and Biotechnology
Real Estate
Professional and Business Services
Legal
Telecommunications
Tobacco
Retail
Transportation
Air Transportation
Maritime Transportation
Rail Transportation
Road Transportation
Utilities
Forestry and Wood Industry
Artsand Culture
Art
Books and Literature
Entertainment
Cinema
Media
Radio and Television
Music
Lifestyleand Leisure
Automotive
Home and Garden
Fashion and Luxury
Textile and Apparel
Food
Travel and Hospitality
Boating and Yachting
Sports
Baseball
Basketball
Boxing
Cricket
Cycling
Football (American)
Football (Australian)
Football (Soccer)
Golf
Hockey
Racing
Rugby
Sailing
Skiing and Winter Sports
Tennis
Volleyball
The security settings of your browser are blocking the execution of scripts.
To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.
If you have changed your browser's security settings, you can click here.
Astellas Pharma US Inc.
Astellas Announces a Partnership with the 'Korea Institute of Startup and Entrepreneurship Development', an Umbrella Organization of the 'Ministry of SMEs and Startups', a Korean Government Agency, for the Operation of the 'Partnership with Global Companies Program'
7/16
XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence
7/10
Mitsubishi Research Institute and Astellas Announce Collaboration to Support Pharma Startups in Japan
6/12
Astellas Enters Exclusive License Agreement with Evopoint Biosciences for XNW27011, a Novel Clinical-stage Antibody-Drug Conjugate Targeting CLDN18.2
5/29
Astellas Announces Second Annual Patient Advocacy Organization (PAO) Action Week™ To Empower Patients and Caregivers
5/28
Astellas and Pfizer's XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer
5/22
Astellas and MBC BioLabs Announce the 2025 Astellas Future Innovator Prize Awarded to DeepSeq.AI & Serna Bio
5/21
Astellas Presents New Data that Explores Potential of its Cancer Therapies at 2025 ASCO Annual Meeting
5/19
Notice of Nominees for Directors
5/7
Astellas to Present New Data in Geographic Atrophy at Upcoming Ophthalmology Annual Congresses
5/1